Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Aging and chronic inflammation weaken the immune system, increasing cancer and infection risks.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

The conclusion is that high-potency steroids or tacrolimus are effective treatments for erosive pustular dermatosis of the scalp.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Scientists have created a new hair loss treatment using ultrasound to deliver gene-editing particles, which resulted in up to 90% hair regrowth in mice.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Skin diseases, especially psoriasis, greatly affect people's quality of life, similar to chronic diseases.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

New treatments for psoriasis have improved effectiveness and may reduce long-term side effects when combined with standard therapies.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

A rare skin rash after COVID-19 vaccination shouldn't stop future vaccinations.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Minoxidil in breast milk may harm nursing infants.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Non-immune factors play a significant role in alopecia areata.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

The WNT signaling pathway is crucial for mesenchymal stem cells' function and therapy success.

Lambs' skin showed similar but more severe responses to a second orf virus infection, involving immune cells and new skin formation.

A patient with complete hair loss regrew all her hair using tofacitinib.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.